Levosimendan for bridging in a pediatric patient with Alström syndrome awaiting heart-lung transplantation

Clin Res Cardiol. 2008 Nov;97(11):846-8. doi: 10.1007/s00392-008-0691-4. Epub 2008 Jul 16.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Abnormalities, Multiple / drug therapy*
  • Abnormalities, Multiple / genetics
  • Abnormalities, Multiple / surgery
  • Adolescent
  • Cardiomyopathy, Dilated / drug therapy*
  • Cardiomyopathy, Dilated / genetics
  • Cardiomyopathy, Dilated / surgery
  • Cardiotonic Agents / therapeutic use*
  • Cell Cycle Proteins
  • Heart-Lung Transplantation*
  • Humans
  • Hydrazones / therapeutic use*
  • Hypertension, Pulmonary / drug therapy*
  • Hypertension, Pulmonary / genetics
  • Hypertension, Pulmonary / surgery
  • Male
  • Proteins
  • Pyridazines / therapeutic use*
  • Simendan
  • Syndrome
  • Treatment Outcome
  • Waiting Lists*

Substances

  • ALMS1 protein, human
  • Cardiotonic Agents
  • Cell Cycle Proteins
  • Hydrazones
  • Proteins
  • Pyridazines
  • Simendan